When your company prepares to bring a new food ingredient into the U.S. market, a dietary exposure assessment is one of the required components of the submission. The FDA uses it to understand how much of a substance people are likely to consume across their entire diet, not just through a single product. Under 21 CFR 170.235, a GRAS notice must include an estimate of dietary exposure to the notified substance that covers its intended use and all other sources in the diet. That last clause is where most of the technical work sits.
For regulatory teams managing several submission timelines at once, understanding why the FDA asks for this helps you scope the work accurately at the start. The agency reviews your methodology as closely as it reviews your final number, so the assessment needs to rest on documented consumption data and a defensible calculation approach rather than figures carried over from a supplier dossier or a European filing.
What Is a Dietary Exposure Assessment?
A dietary exposure assessment estimates how much of a specific substance a person consumes through food over time. The calculation combines two inputs: the concentration of the substance in each food where it will be used, and how much of those foods people actually eat. Multiply and sum across the diet and you get an estimated daily intake (EDI), usually expressed in milligrams per day or milligrams per kilogram of body weight per day.
The estimate is not one number for everyone. Assessments typically report intake for the general population, for age-based subgroups drawn from national survey data, and for high-percentile consumers. A toddler and an adult who drinks four fortified beverages a day sit at very different points on the exposure curve, and the FDA expects to see both ends of that range.
Consumption data comes from What We Eat in America (WWEIA), the dietary interview component of the CDC’s National Health and Nutrition Examination Survey (NHANES). WWEIA collects two days of 24-hour dietary recall from a nationally representative sample, and it is the backbone of nearly every U.S. dietary exposure estimate.
Why the FDA Requires This Assessment
Under sections 201(s) and 409 of the Federal Food, Drug, and Cosmetic Act, a substance added to food is a food additive requiring premarket approval unless its use is generally recognized as safe. Under either pathway, safety is judged under the intended conditions of use, and conditions of use mean nothing without a quantity attached to them.
The exposure estimate is the input that everything downstream depends on. Toxicology studies produce a no-observed-adverse-effect level (NOAEL). Applying an uncertainty factor to that NOAEL gives you an acceptable daily intake (ADI) or a comparable reference value. The FDA then compares your estimated daily intake against that reference value. If intake sits well below it, you have a margin of safety you can describe and defend. Without the exposure number, the toxicology data has nothing to be measured against and the agency cannot reach a conclusion at all.
21 CFR 170.235 makes this explicit, and it applies regardless of whether your GRAS conclusion rests on scientific procedures or on experience based on common use in food before 1958. Both routes require the same exposure data. A documented history of use does not remove the need for a current, quantified estimate.
How the Assessment Connects to Your Submission Pathway
The exposure estimate shapes the whole submission, across GRAS notices, food additive petitions under 21 CFR Part 171, and color additive petitions. The common failure point is scope. An ingredient might appear in beverages, snack foods, sauces, and supplements at the same time, and the FDA expects cumulative intake across all of those uses, not just the first application you launch. Background exposure from foods where the substance already occurs naturally is layered on top of that.
One planning note. GRAS notification is currently voluntary. The FDA proposed a rule in August 2026 that would make it mandatory, which would put more of these exposure files in front of agency reviewers rather than internal expert panels. Quality Smart Solutions (QSS) prepares dietary exposure assessments for all three submission types using the intake methodologies the Office of Food Additive Safety relies on.
The Methodology the FDA Expects You to Follow
The FDA accepts two broad approaches: deterministic point estimates and probabilistic modelling. Which one fits depends on the complexity of your intended uses.
A point estimate multiplies proposed maximum use levels by consumption amounts from WWEIA/NHANES and sums the result across food categories. Standard practice reports both a mean and a high percentile, commonly the 90th, and distinguishes per capita intake, spread across everyone surveyed, from eaters-only intake, limited to people who actually reported consuming the relevant foods. Eaters-only figures are higher and are usually the more conservative and more relevant number for a new ingredient.
Probabilistic models, such as Monte Carlo simulations, sample from distributions of use level and consumption to generate a full distribution of exposure across the population. They give a more nuanced picture of intake variability, and they take considerably more work to build and document.
Background exposure deserves specific attention. If your ingredient is a concentrated form of a compound already present in common foods, the assessment should account for that baseline alongside the intake from your proposed use. Omitting background exposure is a recurring source of follow-up questions from the agency.
Key Data Sources for a U.S. Exposure Assessment
Using recognized data sources strengthens your submission and reduces the likelihood of questions during review. The sources most commonly relied on include:
- WWEIA/NHANES 24-hour dietary recall data, the primary source for U.S. food consumption patterns
- Proposed use levels by food category, documented from your own formulation and technical effect data
- The EPA Food Commodity Intake Database (FCID), which translates survey foods into their component commodities
- USDA food availability and per capita disappearance data, useful for poundage-based cross-checks rather than as a primary basis
- Published intake studies and validated industry consumption surveys, where the methodology is transparent and documented
One clarification worth making. The FDA’s Total Diet Study measures contaminants and nutrients in foods already on the market. It shares the same WWEIA/NHANES consumption backbone, which is where the confusion comes from, but it is not a source for estimating intake of an ingredient you are proposing to introduce.
FAQs on Dietary Exposure Assessment
Is a dietary exposure assessment required even for ingredients already used in food?
Yes. 21 CFR 170.235 requires dietary exposure data regardless of whether your GRAS conclusion is reached through scientific procedures or through experience based on common use in food before 1958. A history of safe use supports your safety narrative, but it does not replace a quantified estimate that reflects current use levels, current consumption patterns, and the full scope of uses in your specific submission. Pairing documented history of use with a current exposure estimate is the combination the FDA is looking for.
What happens if the FDA finds the exposure estimate insufficient?
That depends on your pathway. For a GRAS notice, the FDA responds by letter within 180 days of filing and may extend that timeframe by 90 days as needed, under 21 CFR 170.265(b). Before that response is issued, the agency may ask questions and you may submit an amendment under 21 CFR 170.260(a). There is no clock-stopping deficiency process. If the gaps are not resolved, the response letter can state that the notice does not provide a sufficient basis for a GRAS conclusion, and that letter becomes publicly available.
Some notifiers ask the FDA to cease evaluation and refile a strengthened notice instead. Food additive petitions under Part 171 follow their own review process. In either case, rebuilding an exposure assessment mid-review takes longer than scoping it properly at the outset.
Can one dietary exposure assessment cover multiple food applications?
It can, if it is structured for that from the beginning. A single assessment can address multiple food categories when it models aggregate intake across all intended uses and accounts for each application’s use level and consumption frequency. If your company later expands into categories outside the original scope, the assessment needs to be updated, because your conditions of use have changed and so has the cumulative exposure picture. Building anticipated uses into the initial scope avoids repeating the work.
Key Takeaways
- 21 CFR 170.235 requires dietary exposure data in every GRAS notice, covering the intended use and all other dietary sources, regardless of the basis for the GRAS conclusion
- The estimated daily intake is what makes the toxicology usable, because without it there is nothing to compare against an ADI or a NOAEL-derived reference value
- The assessment must cover cumulative intake across every intended food category, plus background exposure where the substance occurs naturally in food
- WWEIA/NHANES is the primary consumption dataset for U.S. submissions, and the FDA’s Total Diet Study is a contaminant surveillance program rather than a substitute for it
- Methodology is reviewed as closely as the final number, so every data source and assumption needs to be documented and justified
Putting Your Submission on the Right Track
The dietary exposure assessment is one of the more technically demanding parts of a food ingredient submission, and it is also one of the parts the FDA examines most closely. Teams that treat it as a calculation to complete at the end, rather than a scientific argument built alongside the toxicology, tend to be the ones rebuilding it later.
Our dietary exposure assessment service covers methodology selection, the full intake calculation, subgroup analysis, and support if OFAS raises questions during review. Contact us to talk through where your file currently stands.
